The sepsis syndrome in a Dutch university hospital. Clinical observations.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Archives of Internal Medicine

• Publication date

  1993-10-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.1993.00410190081010PMID 8215727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Positive blood cultures in a University Hospital in The Netherlands

  2005cited by this paper
• Evaluation of definitions of sepsis.

  1994cited by this paper
• Evaluation of definitions for sepsis.

  1992cited by this paper
• Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

  1992cited by this paper
• Definitions of sepsis--have we reached a consensus?

  1991cited by this paper
• Monoclonal antibodies and the treatment of gram-negative bacteremia and shock.

  1991cited by this paper
• Let's agree on terminology: Definitions of sepsis

  1991cited by this paper
• Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions.

  1991cited by this paper
• A three-year study of positive blood cultures, with emphasis on prognosis.

  1991cited by this paper
• Definitions of sepsis--have we reached a consensus?

  1991cited by this paper
• Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

  1991cited by this paper
• The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults.

  1991cited by this paper
• Statistical modeling of prognostic indices for evaluation of critically ill patients

  1991cited by this paper
• Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

  1991cited by this paper
• Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices

  1990cited by this paper
• Randomized Placebo-controlled Study of E5 Monoclonal Antiendotoxin Antibody

  1990cited by this paper
• Sepsis syndrome: a valid clinical entity

  1989cited by this paper
• A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock.

  1989cited by this paper
• The septic syndrome. Definition and clinical implications.

  1989cited by this paper
• CDC definitions for nosocomial infections.

  1989cited by this paper
• Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group.

  1989cited by this paper
• Endotoxaemia: an early predictor of septicaemia in febrile patients.

  1988cited by this paper
• Detection of sepsis in the postoperative patient.

  1988cited by this paper
• CDC definitions for nosocomial infections, 1988.

  1988cited by this paper
• An expanded definition of the adult respiratory distress syndrome.

  1988cited by this paper
• A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.

  1987cited by this paper
• Validation of the mortality prediction model for ICU patients

  1987cited by this paper
• Evaluating sepsis in critically ill patients.

  1987cited by this paper
• Cardiovascular Dysfunction in Humans with Septic Shock

  1986cited by this paper
• Hemodynamic determinants of mortality in human septic shock.

  1986cited by this paper
• Changing etiology of nosocomial bacteremia and fungemia and other hospital-acquired infections.

  1985cited by this paper
• APACHE II: A severity of disease classification system

  1985cited by this paper
• APACHE II: a severity of disease classification system.

  1985cited by this paper
• A simplified acute physiology score for ICU patients

  1984cited by this paper
• The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study.

  1984cited by this paper
• Septic shock. Hemodynamics and pathogenesis.

  1983cited by this paper
• Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy.

  1983cited by this paper
• The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis.

  1983cited by this paper
• The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations.

  1983cited by this paper
• Therapeutic Intervention Scoring System: Update 1983

  1983cited by this paper
• The grading of sepsis

  1983cited by this paper
• Gauging the severity of surgical sepsis.

  1983cited by this paper
• Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients

  1980cited by this paper
• A review of positive blood cultures: identification and source of microorganisms and patterns of sensitivity to antibiotics.

  1980cited by this paper
• Disseminated intravascular coagulation: a reappraisal.

  1979cited by this paper
• Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases.

  1975cited by this paper

• 60-hours Sepsis Prediction in ICU Patients

  2024cites this paper
• Antibacterial activities of centrifugally spun polyethylene oxide/silver composite nanofibers

  2021cites this paper
• Emerging antimicrobial resistance causing therapeutic failure in neonatal sepsis

  2019cites this paper
• The epidemiology and characteristics of sepsis in Norwegian hospitals

  2018influential citation
• Glasgow Coma Scale in Anticipation of Sepsis and Septic Shock: Review Article

  2017cites this paper
• An observational study of community‐acquired severe sepsis comparing intensive care and non‐intensive care patients

  2017cites this paper
• The antimicrobial susceptibility patterns in patients with blood culture positive sepsis at the accident and emergency department Kenyatta National Hospital

  2016cites this paper
• Évaluation de l'intérêt diagnostique du dosage de la procalcitonine dans la pneumonie d'inhalation communautaire de l'adulte

  2015cites this paper
• Staphopains in Staphylococcus aureus bacteremia: Virulence activities related to the onset of septic shock, coagulation disorders, and infectious endocarditis

  2014cites this paper
• Topical antibiotics as a major contextual hazard toward bacteremia within selective digestive decontamination studies: a meta-analysis

  2014cites this paper
• B-Type Natriuretic Peptide A Biomarker for the Diagnosis and Risk Stratification of Patient with Sepsis and Septic Shock

  2013cites this paper
• Pneumonia‐induced sepsis in mice: temporal study of inflammatory and cardiovascular parameters

  2013cites this paper
• Vascular Dysfunction following Polymicrobial Sepsis: Role of Pattern Recognition Receptors

  2012cites this paper
• PROG OSTIC FACTORS I PATIE TS WITH SEPSIS

  2011cites this paper
• Degradation of fibrinogen and collagen by staphopains, cysteine proteases released from Staphylococcus aureus.

  2011cites this paper
• Frequency of Pathogens and Antimicrobial Susceptibility of Bacteria Isolated from Bloodstream Infections

  2010cites this paper
• Sepsis, Severe Sepsis, and Septic Shock

  2010cites this paper
• Review of recent guidelines for the management of severe sepsis and septic shock

  2010cites this paper
• Antibacterial therapy of adult patients with Sepsis

  2010cites this paper
• The diagnostic value of serum leptin monitoring and its correlation with tumor necrosis factor-α in critically ill patients: a prospective observational study

  2010cites this paper
• Estudio epidemiológico de la sepsis en unidades de terapia intensiva mexicanas

  2009cites this paper
• Estudio epidemiológico de la sepsis en unidades de terapia intensiva mexicanas

  2009cites this paper
• Lipoprotein Lipase and Hydrofluoric Acid Deactivate Both Bacterial Lipoproteins and Lipoteichoic Acids, but Platelet-Activating Factor-Acetylhydrolase Degrades Only Lipoteichoic Acids

  2009cites this paper
• [Epidemiological study of sepsis in Mexican intensive care units].

  2009cites this paper
• Approach to the patient with sepsis.

  2009cites this paper
• Immunmodulation of serum in orthopaedic trauma.

  2009cites this paper
• Aus der Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie Universitätskliniken des Saarlandes, Homburg/Saar

  2009cites this paper
• Adrenal functions in patients with sepsis.

  2009cites this paper
• The Characteristics and Prognostic Factors of Severe Sepsis in Patients Who Were Admitted to a Medical Intensive Care Unit of a Tertiary Hospital

  2009cites this paper
• Severe sepsis and septic shock in the emergency department.

  2008cites this paper
• Differences in LPS and PepG Induced Release of Inflammatory Cytokines in Orthopedic Trauma

  2008cites this paper
• Prise en charge initiale des états septiques graves de l’adulte et de l’enfant Initial management of severe sepsis in adults and children

  2007cites this paper
• [Initial management of severe sepsis in adults and children].

  2007cites this paper
• Antagonism of Lipopolysaccharide-Induced Blood Pressure Attenuation and Vascular Contractility

  2007cites this paper
• Prise en charge initiale des états septiques graves de l'adulte et de l'enfant

  2007cites this paper
• Commentary: Trzeciak S et al. (2006). Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department.

  2007cites this paper
• Prise en charge initiale des états septiques graves de l'adulte et de l'enfant

  2007cites this paper
• [Epidemiology of severe sepsis at a German university hospital].

  2007cites this paper
• Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery?

  2007cites this paper
• Histopathologische Veränderungen am Skelettmuskel nach chronischer Inflammation mit Corynebacterium parvum mit und ohne Immobilisation-Experimentelle Untersuchungen an der Ratte

  2007cites this paper
• Epidemiologie der schweren Sepsis an einem deutschen Universitätsklinikum

  2007cites this paper
• Groupe Transversal Sepsis « Prise en charge initiale des états septiques graves de l'adulte et de l'enfant »

  2006cites this paper
• Plasminogen Activator Inhibitor 1 Promotes a Poor Prognosis in Sepsis-Induced Disseminated Intravascular Coagulation

  2006cites this paper
• Prise en charge initiale des états septiques graves de l’adulte et de l’enfant Early management of severe sepsis and shock in children and adults

  2006cites this paper
• Mise au point Prise en charge initiale des états septiques graves de l ’ adulte et de l ’ enfant Early management of severe sepsis and shock in children and adults Groupe transversal sepsis

  2006cites this paper
• [Epidemiology of severe sepsis].

  2006cites this paper
• [An epidemiological study of sepsis in Intensive Care Units: Sepsis Brazil study].

  2006cites this paper
• Sepse Brasil: estudo epidemiológico da sepse em Unidades de Terapia Intensiva brasileiras

  2006cites this paper
• Épidémiologie des états septiques graves

  2006cites this paper
• [The cost of sepsis].

  2006cites this paper
• Severe sepsis and septic shock: review of the literature and emergency department management guidelines.

  2006cites this paper
• Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus

  2005cites this paper
• Definition und Diagnose von Sepsis und Multiorganversagen

  2005cites this paper
• Systemic inflammatory response and progression to severe sepsis in critically ill infected patients.

  2005cites this paper
• Septic shock; current pathogenetic concepts from a clinical perspective.

  2005cites this paper
• Epidemiologische und ökonomische Aspekte der Sepsis

  2005cites this paper
• Sepsis: still going strong.

  2005cites this paper
• Incidence and Definition of Sepsis and Associated Organ Dysfunction

  2004cites this paper
• An international sepsis survey: a study of doctors' knowledge and perception about sepsis

  2004cites this paper
• Prevalence and incidence of severe sepsis in Dutch intensive care units

  2004cites this paper
• Research Prevalence and incidence of severe sepsis in Dutch intensive care

  2004cites this paper
• Nosocomial Bloodstream Infection and Clinical Sepsis

  2004cites this paper
• Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients.

  2003cites this paper
• The epidemiology of sepsis in the United States from 1979 through 2000.

  2003cites this paper
• Evidence-based medicine in infectious diseases and microbiology: Still a long way to go

  2003cites this paper
• Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland

  2003cites this paper
• Severe Sepsis and Septic Shock: Defining the Clinical Problem

  2003cites this paper
• [Sepsis--diagnostic and therapeutic approaches].

  2003cites this paper
• Entwicklungen in der Sepsis-Therapie und aktuelle Behandlungskonzepte

  2003cites this paper
• Sepsa - pristup dijagnostici i lecenju

  2003cites this paper
• THE INFLUENCE OF SIRS AND SEPSIS ON OUTCOME OF CRITICALLY ILL INFECTED PATIENTS

  2003cites this paper
• Evolving Concepts and Challenges in Sepsis and MODS

  2002cites this paper
• The pathophysiology of Gram-positive shock

  2002cites this paper
• The Sources of Sepsis

  2002cites this paper
• Sepsis y shock séptico

  2002cites this paper
• Septic shock and multiple organ failure after hematopoietic stem cell transplantation: treatment with recombinant human activated protein C

  2002cites this paper
• Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit

  2002cites this paper
• Disseminating InfectionsA Clinical Overview

  2002cites this paper
• Prediction of shock in febrile medical patients with a clinical infection

  2001cites this paper
• Staphylococcus aureus Induces Release of Bradykinin in Human Plasma

  2001cites this paper
• Definition of sepsis

  2001cites this paper
• New strategies for clinical trials in patients with sepsis and septic shock

  2001cites this paper
• Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

  2001cites this paper
• Epidemiology of sepsis: An update

  2001cites this paper
• Complicaciones laparoscópicas en la cirugía ginecológica: experiencia de la escuela de endoscopia ginecológica de la Universidad de Kiel

  2001cites this paper
• Update On Sepsis: Pathophysiology And Treatment

  2000cites this paper
• The Epidemiology and Outcome of Patients with Sepsis: Clear as Mud

  2000cites this paper
• Presentation and Clinical Features of Severe Sepsis

  2000cites this paper
• Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group.

  2000cites this paper
• Presentation and clinical features of severe sepsis Septicaemia

  2000cites this paper
• The epidemiology of the systemic inflammatory response

  2000influential citation
• The role of bacterial superantigens in sepsis and treatment implications

  2000cites this paper
• Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998.

  2000cites this paper
• Pharmacokinetics of the nitric oxide synthase inhibitor L‐NG‐methylarginine hydrochloride in patients with septic shock

  1999cites this paper
• Procalcitonin used as a marker of infection in the intensive care unit.

  1999cites this paper
• The epidemiology of bacterial sepsis.

  1999cites this paper
• Treating patients with severe sepsis.

  1999cites this paper
• The clinical host response to microbial infection in medical patients with fever.

  1999cites this paper
• Epidemiología de la sepsis bacteriana

  1999cites this paper
• Prediction of microbial infection and mortality in medical patients with fever: plasma procalcitonin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables.

  1999cites this paper